Society for Inherited Metabolic Disorders
The Society for Inherited Metabolic Disorders (SIMD) is a US 501(c)(3) nonprofit professional society founded in 1978 that serves metabolic medicine physicians, biochemical geneticists, dietitians, genetic counselors, and researchers through education (NAMA, MBG-CCSS), its journal Molecular Genetics and Metabolism, annual meetings, and policy advocacy on newborn screening and rare metabolic disorders.
- Company typePrivate
- Founded1978
- HeadquartersWest Linn, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Society for Inherited Metabolic Disorders does
The Society for Inherited Metabolic Disorders (SIMD) is a 501(c)(3) nonprofit professional society founded in 1978 and headquartered in the United States, dedicated to advancing research, education, and clinical care for inborn errors of metabolism (IEM). Its members are physicians, biochemical geneticists, metabolic dietitians, genetic counselors, laboratorians, and basic/clinical researchers who apply for admission and are approved by member vote. SIMD operates through a Board of Directors (President, President-Elect, Past President, Treasurer, Secretary, Directors-at-Large, and committee chairs) with a new Executive Director (Kristi S. Wees, appointed January 2025) leading day-to-day operations; Leslie Lublink serves as consultant and the Secretariat is hosted at Duke University.
SIMD's core product surface consists of educational and clinical resources rather than commercial technology: the North American Metabolic Academy (NAMA) with over 70 PowerPoint lectures hosted at simdnama.org; the Medical Biochemical Genetics Clinical Core Seminar Series (MBG-CCSS) originating at the University of Colorado Anschutz Medical Campus and distributed via YouTube; IEMbase (freely available at iembase.org) and the Case Database of Inherited Metabolic Disorders (CDB-IMD at imd-casesdatabase.org) for browsing and case sharing; the official journal Molecular Genetics and Metabolism published via Elsevier/ScienceDirect; specialty-bucketed online discussion groups; an awards program (Emmanuel Shapira Award, Buist Founders' Award, SIMD-Hyperion Fellowship, JSIMD Young Investigator Presentation Award); and annual plus ad-hoc virtual programming (Expert Webinars, Fellow Journal Club, FDA/SIMD joint webinars, Laboratory Workgroup Webinar Series).
Revenue mechanics combine annual membership dues tiered from $45 (developing-nation trainee) to $295 (regular and affiliate), annual scientific meeting registration with rotating locations (2024 Charlotte co-located with GMDI; 2027 Tucson; ICIEM 2029 Toronto), pharmaceutical sponsorships at Diamond through Bronze levels (Amgen, BioMarin, PTC Therapeutics, Ultragenyx as core supporters), and Elsevier journal distribution. Financial details are not publicly disclosed (FY2007 fund balance was approximately $316K including a $160K restricted NAMA account). The society maintains formal collaborations with ACMG, GMDI, ICIEM, SSIEM, JSIMD, and FDA/Office of New Drugs, and engages in public-policy advocacy on newborn screening, ACHDNC, and medical foods.
Society for Inherited Metabolic Disorders firmographics
Firmographics- Name
- Society for Inherited Metabolic Disorders
- Legal name
- Society for Inherited Metabolic Disorders
- Website
- https://simd.org
- Company type
- Private
- Founded year
- 1978
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- The Society for Inherited Metabolic Disorders (SIMD) is a US 501(c)(3) nonprofit professional society founded in 1978 that serves metabolic medicine physicians, biochemical geneticists, dietitians, genetic counselors, and researchers through education (NAMA, MBG-CCSS), its journal Molecular Genetics and Metabolism, annual meetings, and policy advocacy on newborn screening and rare metabolic disorders.
- Ownership category
- akta.pro rank
Society for Inherited Metabolic Disorders industry classification
Industry- Product category
- Professional Medical Association
- NAICS
- Professional Organizations (81392)
- akta.pro primary industry
- Genetic & Genomic Rare Disease Therapeutics (HLAIAIAA)
Keywords
Where Society for Inherited Metabolic Disorders is headquartered
LocationHeadquarters
- HQ city
- West Linn
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Society for Inherited Metabolic Disorders business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Membership Dues: Annual dues from members form the primary recurring revenue stream. Dues categories include Regular ($295/yr), Non-Doctoral ($130/yr), Trainee ($130/yr up to 3 years), Affiliate ($295/yr), Emeritus ($0-$95/yr), and Developing Nation ($130/yr or $45/yr for trainees). Dues are invoiced annually in May or June.
- Annual Meeting Registration: Registration fees for annual scientific meetings. Meetings frequently co-locate with ACMG, GMDI, or international ICIEM events, generating additional registration revenue. Pharmaceutical company sponsors provide financial support at various levels (Diamond, Platinum, Gold, Silver, Bronze).
- Journal Subscription: Annual subscription to Molecular Genetics and Metabolism is included in membership dues (except for Emeritus without MGM option). Individual online access and subscription changes handled through Elsevier.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Regular Member - $295/year |
| Subscription | Annual | Non-Doctoral Member - $130/year |
| Subscription | Annual | Trainee Member - $130/year |
| Subscription | Annual | Affiliate Membership - $295/year |
| Subscription | Annual | Emeritus Member - $0 or $95/year |
| Subscription | Annual | Developing/Other Nation Member - $130/year |
| Subscription | Annual | Developing/Other Nation Trainee/Associate - $45/year |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels6 records
Society for Inherited Metabolic Disorders product offering
Product offeringCore offering
The Society for Inherited Metabolic Disorders (SIMD) is a 501(c)(3) nonprofit professional society that serves clinicians, scientists, genetic counselors, dietitians, and trainees working in inherited metabolic disorders. It delivers educational programs such as the North American Metabolic Academy (NAMA) and the MBG-CCSS seminar series, operates knowledgebases including IEMbase and the Case Database of Inherited Metabolic Disorders (CDB-IMD), publishes the Molecular Genetics and Metabolism journal, and convenes its Annual Scientific Meeting. SIMD also advocates for the field through policy engagement and partnerships with ACGME, ACIMD, ABMGG, JSIMD, the Gemon Foundation, and NORD.
Product overview
SIMD is a professional organization that provides educational resources, publications, and member services for professionals in inherited metabolic disorders. Its core offerings include the North American Metabolic Academy (NAMA) with over 70 PowerPoint presentations, the Medical Biochemical Genetics Clinical Core Seminar Series (MBG-CCSS), and the Molecular Genetics and Metabolism journal as its official publication. Additional services include discussion groups organized by professional category (Clinicians, Dietitians, Nurses, Laboratorians, Counselors, Basic/Clinical Research), an awards program recognizing excellence in the field, and access to knowledgebases including IEMbase and the Case Database of Inherited Metabolic Disorders.
Differentiator
Problem solved
Functional benefit
Products and services
- North American Metabolic Academy (NAMA) Formal education program providing specialized training in inherited metabolic disorders for clinicians, scientists, genetic counselors, and dietitians
- MBG-CCSS Seminar Series Regular seminar series for metabolic disease specialists delivered through SIMD's online educational platform
- IEMbase Specialized knowledgebase for inherited metabolic disorders used by metabolic disease professionals
- Case Database of Inherited Metabolic Disorders (CDB-IMD) Case database of inherited metabolic disorders with an Aggregated website for case submissions and reference
- Annual Scientific Meeting SIMD's annual scientific meeting for metabolic disease clinicians, researchers, and trainees, supported by Diamond, Platinum, Gold, Silver, and Bronze sponsors
- Molecular Genetics and Metabolism Journal Peer-reviewed scientific journal published in partnership with Elsevier, focused on molecular genetics and metabolism research
- Discussion Groups Platform Member-only online discussion groups for peer collaboration among SIMD members
- SIMD Awards Program Society awards recognizing contributions to the inherited metabolic disorders field
Quantifiable outcome
- NAMA offers >70 professional educational presentations covering broad range of metabolic disease topics
- +2 more outcomes
Companies that use Society for Inherited Metabolic Disorders
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles2 records
Society for Inherited Metabolic Disorders technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Society for Inherited Metabolic Disorders partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core and minor.
- American College of Medical Genetics and Genomics (ACMG)coreSIMD holds joint sessions with ACMG at annual meetings. 2023 meeting co-located with ACMG in Salt Lake City. 2019 meeting featured joint session in Seattle with ACMG. Ongoing collaboration on meetings and policy.
- Genetic Metabolic Dietitians International (GMDI)coreSIMD2024 annual meeting held in conjunction with GMDI annual meeting immediately following SIMD meeting in Charlotte. Joint sessions and shared attendance.
- International Congress of Inborn Errors of Metabolism (ICIEM)coreSIMD co-hosts ICIEM meetings approximately every 4 years. Past: 2013 Barcelona, 2017 Rio de Janeiro. Upcoming: 2029 Toronto. SIMD provides travel awards for trainees to attend.
- SSIEM (Society for the Study of Inborn Errors of Metabolism)coreSSIEM holds annual meetings in Europe. SIMD lists SSIEM events (2026 Helsinki, 2027 Dublin, 2030 Basel) on meetings page. International collaboration on metabolic disorder research.
- Japanese Society for Inherited Metabolic Disorders (JSIMD)minorEstablished 2019 JSIMD Young Investigator Presentation award to bring JSIMD-selected young investigator to SIMD annual meeting. Collaborative recognition of trainees.
- U.S. FDA/Office of New Drugs (OND)minorListed as Non-Commercial/Parent Support Group supporter of SIMD2024. FDA/SIMD Webinars on regulatory perspectives including clinical outcome assessments in clinical trials for IEM.
- Children's Hospital of Philadelphia (CHOP)minorNon-Commercial supporter of SIMD2024. CHOP faculty participate in SIMD education including MBG-CCSS lectures and award recipients.
- National PKU AllianceminorNon-Commercial/Parent Support Group supporter of SIMD2024. Represents patient community for phenylketonuria.
- United Mitochondrial Disease FoundationminorNon-Commercial supporter of SIMD2024. Patient advocacy organization for mitochondrial disorders.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
Society for Inherited Metabolic Disorders competitors and assessment
Company assessmentDirect peers
- Japanese Society for Inherited Metabolic Disorders (JSIMD): National counterpart IEM society. SIMD and JSIMD jointly administer the Young Investigator Presentation Award since 2019, demonstrating formal cross-border peer collaboration on trainee recognition.
- International Congress of Inborn Errors of Metabolism (ICIEM): Quadrennial international IEM congress co-hosted by SIMD with SSIEM and other societies. Serves the same clinician-researcher audience as SIMD's annual meeting but at global scale (2029 Toronto upcoming).
- Genetic Metabolic Dietitians International (GMDI): Co-locates annual meetings with SIMD (most recently Charlotte 2024) and serves the dietitian segment of the IEM professional community. Closest operational peer with shared audience and educational programming.
- Society for the Study of Inborn Errors of Metabolism (SSIEM): European/international IEM society with parallel mission, membership model, and annual meeting structure. SIMD cross-lists SSIEM events on its meetings page, indicating tight functional equivalence as a sister society.
Others
- Association for Molecular Pathology (AMP): Society for molecular pathology professionals including biochemical genetics laboratorians — a SIMD member category. Adjacent specialty with shared laboratory audience but different primary focus.
- National PKU Alliance (NPKUA): Patient advocacy organization for phenylketonuria, a core SIMD disease area. Listed as a Non-Commercial supporter of SIMD2024. Adjacent ecosystem participant rather than direct competitor.
Emerging players
- National Society of Genetic Counselors (NSGC): U.S. society for genetic counselors — a segment SIMD serves through its dedicated Counselor discussion group. Partial overlap on IEM clinical topics but distinct professional identity.
Broad incumbents
- American Society of Human Genetics (ASHG): Largest U.S. human genetics society with annual meeting drawing 8,000+ attendees. Many SIMD members also attend ASHG; broader scope includes IEM but lacks SIMD's clinical specialty focus.
- European Society of Human Genetics (ESHG): European counterpart to ASHG. Similar broader society model with overlapping IEM basic-research content but different geographic focus than SIMD.
- American College of Medical Genetics and Genomics (ACMG): Larger medical genetics professional society (3,000+ members) that co-hosts joint sessions with SIMD (Salt Lake City 2023, Seattle 2019). Broader mandate captures overlapping IEM content but lacks SIMD's specialty depth.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Society for Inherited Metabolic Disorders social profiles
Digital presenceSociety for Inherited Metabolic Disorders financial estimates
Financial estimateRevenue estimate
Valuation estimate
Society for Inherited Metabolic Disorders leadership team
Management profileNumber of profiles
Society for Inherited Metabolic Disorders funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Society for Inherited Metabolic Disorders M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Society for Inherited Metabolic Disorders
What does Society for Inherited Metabolic Disorders do?
The Society for Inherited Metabolic Disorders (SIMD) is a 501(c)(3) nonprofit professional society that serves clinicians, scientists, genetic counselors, dietitians, and trainees working in inherited metabolic disorders. It delivers educational programs such as the North American Metabolic Academy (NAMA) and the MBG-CCSS seminar series, operates knowledgebases including IEMbase and the Case Database of Inherited Metabolic Disorders (CDB-IMD), publishes the Molecular Genetics and Metabolism journal, and convenes its Annual Scientific Meeting. SIMD also advocates for the field through policy engagement and partnerships with ACGME, ACIMD, ABMGG, JSIMD, the Gemon Foundation, and NORD.
Is Society for Inherited Metabolic Disorders a public or private company?
Society for Inherited Metabolic Disorders is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Society for Inherited Metabolic Disorders founded?
Society for Inherited Metabolic Disorders was founded in 1978. It employs 51 to 100 people.
Where is Society for Inherited Metabolic Disorders based?
Society for Inherited Metabolic Disorders is headquartered in West Linn, United States, in the North America region.
How does Society for Inherited Metabolic Disorders make money?
Three revenue lines are on record. Membership Dues are the primary driver. The others are annual Meeting Registration and journal Subscription.
Who are Society for Inherited Metabolic Disorders's main competitors?
Direct peers on record are Japanese Society for Inherited Metabolic Disorders (JSIMD), International Congress of Inborn Errors of Metabolism (ICIEM), Genetic Metabolic Dietitians International (GMDI) and Society for the Study of Inborn Errors of Metabolism (SSIEM). Others are Association for Molecular Pathology (AMP) and National PKU Alliance (NPKUA). National Society of Genetic Counselors (NSGC) is listed as an emerging player. Broad incumbents are American Society of Human Genetics (ASHG), European Society of Human Genetics (ESHG) and American College of Medical Genetics and Genomics (ACMG).
Does Society for Inherited Metabolic Disorders have an API?
No public API is recorded for Society for Inherited Metabolic Disorders.
What industry is Society for Inherited Metabolic Disorders in?
Society for Inherited Metabolic Disorders's product category is Professional Medical Association. Its primary akta.pro industry code is HLAIAIAA, Genetic & Genomic Rare Disease Therapeutics. Its NAICS code is 81392.